FLAGSTAFF, Ariz., April 26, 2017 /PRNewswire/ -- SenesTech, Inc.
(NASDAQ: SNES), a leader in technology for managing animal pest
populations through fertility control, announced today that
Thomas Chesterman, chief financial
officer, will present at the Pioneers 2017 Conference on
Tuesday, May 2, 2017 at 9:30am ET (6:30am
PT) in the Lotus East room. The conference is being held at
the Mandarin Oriental Hotel in New York
City.
Mr. Chesterman will be available for one-on-one meetings during
the Conference. Investors interested in arranging a meeting with
management should contact their Joseph
Gunnar & Co. representative or Lytham Partners at (602)
889-9700.
The presentation will be available on the company's website at
senestech.investorroom.com.
About SenesTech
SenesTech has developed an innovative technology for managing
animal pest populations through fertility control as opposed to a
lethal approach.
The Company's first fertility control product,
ContraPest®, is marketed for use initially in
controlling rat infestations. ContraPest's novel technology
and approach targets the reproductive capabilities of both sexes,
inducing egg loss in female rodents and impairing sperm development
in males. Using proprietary bait stations, ContraPest is
dispensed in a highly palatable liquid formulation that promotes
sustained consumption by rodent communities. ContraPest is
designed, formulated and dispensed to be safe for handlers and
non-target species such as wildlife, livestock and pets, in a
biodegradable product. In contrast, the historical approach to
managing rodent pest populations, rodenticides, carries a high risk
of environmental contamination and the poisoning of non-target
animals, pets and children.
We believe our non-lethal approach, targeting reproduction, is
more humane, less harmful to the environment, and more effective in
providing a sustainable solution to pest infestations than
traditional lethal pest management methods. There is currently no
other non-lethal fertility control product approved by the Food and
Drug Administration (FDA), or the Environmental Protection Agency
(EPA), for the management of rodent populations. We believe
ContraPest® will establish a new paradigm in rodent
control, resulting in improved performance in rodent control over
rodenticides, without the negative environmental effects of
rodenticides. For more information visit the SenesTech
website at www.senestech.com.
Safe Harbor Statement
This release contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors and other risks
identified in our filings with the Securities and Exchange
Commission. All forward-looking statements contained in this press
release speak only as of the date on which they were made and are
based on management's assumptions and estimates as of such date. We
do not undertake any obligation to publicly update any
forward-looking statements, whether as a result of the receipt of
new information, the occurrence of future events or
otherwise.
CONTACT:
Investor: Robert Blum,
Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,
senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc, 928-779-4143
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/senestech-to-present-at-the-2017-joseph-gunnar-pioneers-conference-in-new-york-city-on-may-2-300445888.html
SOURCE SenesTech, Inc.